TY - JOUR
AU - B. Shuey
AU - D. Lee
AU - I. Ugalde
AU - S. Borgan
AU - C. Bresnan
AU - M. Qureshi
AU - R. Mhaskar
AU - A. Oxner
A1 - 
AB - OBJECTIVE: To determine internal medicine (IM) residents' knowledge of, attitudes towards, and barriers to prescribing buprenorphine for opioid use disorder (OUD). METHODS: We conducted a cross-sectional study of IM residents across all 35 Accreditation Council for Graduate Medical Education (ACGME) accredited Florida IM residency programs. We used an online survey to collect information about resident demographics, substance use curriculums, career interests, content knowledge about diagnosing and managing OUD, and attitudes about and barriers to prescribing buprenorphine for OUD. We used Chi-square test to explore differences in interest in prescribing buprenorphine. We created a composite knowledge score and investigated distribution of knowledge among characteristics via Mann-Whitney U test. RESULTS: There were 161 participants (response rate 16.0%, n = 1008) across 35 programs Seventy-seven percent of residents provided care for patients with OUD more than once per month. Seventy-four percent report no buprenorphine prescribing training. Higher knowledge scores, interest in primary care, being an intern, and caring for patients with OUD more than monthly were associated with interest in obtaining a buprenorphine waiver (P < 0.05). Limited knowledge about OUD was the most important barrier to prescribing buprenorphine. Eighty-nine percent support legislation to deregulate buprenorphine. CONCLUSIONS: Knowledge about managing OUD was poor and represented the most commonly cited barrier to prescribing buprenorphine. Residents want to expand their role in treating OUD. Our findings warrant incorporating addiction medicine into residency curriculum standards. Legislation removing the buprenorphine waiver requirement may increase the number of resident buprenorphine prescribers and improve treatment options for patients with opioid addiction.
AD - Department of Internal Medicine, University of South Florida, 17 Davis Blvd, Suite 308, Tampa, FL 33606 (BS, DL, CB, RM, AO); Department of Internal Medicine, Mount Sinai Medical Center, Miami, 4300 Alton Road, Miami Beach, FL 33140 (IU); Department of Internal Medicine, University of Central Florida College of Medicine, 6850 Lake Nona Blvd, Orlando, FL 32827 (SB, MQ).
BT - Journal of addiction medicine
C5 - Education & Workforce; Measures; Opioids & Substance Use
CY - United States
DO - 10.1097/ADM.0000000000000750
JF - Journal of addiction medicine
LA - eng
M1 - Journal Article
N2 - OBJECTIVE: To determine internal medicine (IM) residents' knowledge of, attitudes towards, and barriers to prescribing buprenorphine for opioid use disorder (OUD). METHODS: We conducted a cross-sectional study of IM residents across all 35 Accreditation Council for Graduate Medical Education (ACGME) accredited Florida IM residency programs. We used an online survey to collect information about resident demographics, substance use curriculums, career interests, content knowledge about diagnosing and managing OUD, and attitudes about and barriers to prescribing buprenorphine for OUD. We used Chi-square test to explore differences in interest in prescribing buprenorphine. We created a composite knowledge score and investigated distribution of knowledge among characteristics via Mann-Whitney U test. RESULTS: There were 161 participants (response rate 16.0%, n = 1008) across 35 programs Seventy-seven percent of residents provided care for patients with OUD more than once per month. Seventy-four percent report no buprenorphine prescribing training. Higher knowledge scores, interest in primary care, being an intern, and caring for patients with OUD more than monthly were associated with interest in obtaining a buprenorphine waiver (P < 0.05). Limited knowledge about OUD was the most important barrier to prescribing buprenorphine. Eighty-nine percent support legislation to deregulate buprenorphine. CONCLUSIONS: Knowledge about managing OUD was poor and represented the most commonly cited barrier to prescribing buprenorphine. Residents want to expand their role in treating OUD. Our findings warrant incorporating addiction medicine into residency curriculum standards. Legislation removing the buprenorphine waiver requirement may increase the number of resident buprenorphine prescribers and improve treatment options for patients with opioid addiction.
PP - United States
PY - 2020
SN - 1935-3227; 1932-0620
T1 - Evaluation of Resident Physicians' Knowledge Of and Attitudes Towards Prescribing Buprenorphine for Patients with Opioid Use Disorder
T2 - Journal of addiction medicine
TI - Evaluation of Resident Physicians' Knowledge Of and Attitudes Towards Prescribing Buprenorphine for Patients with Opioid Use Disorder
U1 - Education & Workforce; Measures; Opioids & Substance Use
U2 - 33079729
U3 - 10.1097/ADM.0000000000000750
VO - 1935-3227; 1932-0620
Y1 - 2020
Y2 - Oct 19
ER -